Eterna Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $1 | $487 | $47 | $47 |
Gross Profit | 1 | 547 | -48 | -555 |
EBITDA | -2,197 | -24,455 | -4,151 | -5,316 |
EBIT | -2,265 | -24,906 | -4,729 | -5,857 |
Net Income | -5,759 | -26,604 | -5,529 | -6,647 |
Net Change In Cash | 1 | 487 | 47 | 47 |
Free Cash Flow | -3,545 | -6,304 | -2,508 | -3,848 |
Cash | 1,729 | 4,264 | 2,586 | 5,116 |
Basic Shares | 13,647 | 5,410 | 5,410 | 5,410 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $582 | $68 | $0 | $0 |
Gross Profit | 486 | -168 | -497 | -459 |
EBITDA | -36,119 | -19,934 | -33,217 | -121,947 |
EBIT | -37,757 | -21,057 | -33,714 | -122,406 |
Net Income | -44,539 | -21,668 | -24,579 | -122,306 |
Net Change In Cash | 582 | 68 | 0 | 0 |
Free Cash Flow | -16,205 | -20,427 | -21,273 | -23,642 |
Cash | 1,729 | 7,575 | 11,446 | 16,985 |
Basic Shares | 13,647 | 5,314 | 3,051 | 2,165 |
Earnings Calls
| Quarter | EPS |
|---|---|
2023-09-30 | -$1.03 |
2023-06-30 | -$0.85 |
2023-03-31 | -$1.24 |
2022-12-31 | -$1.24 |
